Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead Optimization.
Kusumoto Y, Hayashi K, Sato S, Yamada T, Kozono I, Nakata Z, Asada N, Mitsuki S, Watanabe A, Wakasa-Morimoto C, Uemura K, Arita S, Miki S, Mizutare T, Mikamiyama H.
Kusumoto Y, et al. Among authors: nakata z.
ACS Med Chem Lett. 2022 Sep 1;13(10):1634-1641. doi: 10.1021/acsmedchemlett.2c00310. eCollection 2022 Oct 13.
ACS Med Chem Lett. 2022.
PMID: 36262395
Free PMC article.